NAMPT and neoplasm: A total of 9 (64.3%) of 14 progressing patients with a score of ≥ 5 had tissue visfatin > 50% and tumor size ≥ 2 cm, followed by non-HT, LN metastasis and age > 50 years (57.1%; 8/14).